bumecain has been researched along with Coronary Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aloian, GA; Dzhanpoladian, EG; Karagezian, KG; Sambelian, VM | 1 |
| Kirichenko, LL; Masenko, VP; Morozova, LM; Narynskiĭ, AK; Nikitin, AE | 1 |
| Kirilenko, LL; Narynskiĭ, AK; Orlov, VN; Smirnov, VV | 1 |
3 other study(ies) available for bumecain and Coronary Disease
| Article | Year |
|---|---|
[Effect of anti-angina therapy on phospholipid levels of the myocardium in ischemic lesions].
Topics: Animals; Coronary Disease; Dioxanes; Male; Myocardium; Nitroglycerin; Phospholipids; Propranolol; Pyrrolidines; Rats | 1988 |
[Effect of anti-arrhythmia preparations on thrombocytic and vascular hemostasis].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Blood Platelets; Blood Vessels; Coronary Disease; Female; Hemostasis; Humans; Lidocaine; Male; Middle Aged; Platelet Aggregation; Prostaglandins F; Pyrrolidines; Thromboxane B2; Time Factors | 1986 |
[Effect of pyromecaine on cellular hemostasis].
Topics: Adult; Aged; Coronary Disease; Erythrocyte Aggregation; Humans; Male; Middle Aged; Platelet Aggregation; Pyrrolidines | 1985 |